Vancouver, British Columbia — (June 30, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company“), a biotechnology company focused on developing psychedelic medicines to treat addiction, is pleased to […]
Bradenton, Florida, June 24, 2021 (GLOBE NEWSWIRE) — 808 Renewable Energy Corporation (OTC Pink: RNWR) (“808” or the “Company”), today announced that the Company has received its NHTSA (National Highway and Transportation Safety Administration Manufacturer […]
Maya has developed a measurement-based care platform designed to support psychedelic practitioners and patients. […]
is pleased to announce results from the initial six drill holes of the recently completed 12 hole 7,425 foot Phase II RC drill program at the Independence project, south of Battle Mountain, Nevada. […]
To drive brand awareness of, and access to, HaluGen’s Psychedelics Genetic Test Kit […]
FARMINGTON HILLS, Mich., June 11, 2021 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on development and commercialization of therapies for the treatment of several eye disorders, today announced […]
HaluGen Life Sciences’ test evaluates an individual’s overall sensitivity and risk profile associated with psychedelic-assisted therapy […]
Vancouver, British Columbia – June 9, 2021 – (CSE: IGLD, OTCQB:GIDMF, FRA:6NN) (the “Company” or “IGLD“) is pleased to announce it has completed its previously announced non-brokered private placement financing (the “Private Placement”) and has […]
FARMINGTON HILLS, Mich., June 04, 2021 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders, today announced it […]
Budd Hutt continues to pave the way to open the next store in Vermilion, Alberta in June 2021. […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com